Cargando…
Antiseizure medication discovery: Recent and future paradigm shifts
Despite the ever‐increasing number of available options for the treatment of epilepsies and the remarkable advances on the understanding of their pathophysiology, the proportion of refractory patients has remained approximately unmodified during the last 100 years. How efficient are we translating p...
Autor principal: | Talevi, Alan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340309/ https://www.ncbi.nlm.nih.gov/pubmed/35090197 http://dx.doi.org/10.1002/epi4.12581 |
Ejemplares similares
-
Capturing seizures in clinical trials of antiseizure medications for KCNQ2‐DEE
por: Millichap, John J., et al.
Publicado: (2021) -
Molecular Docking: Shifting Paradigms in Drug Discovery
por: Pinzi, Luca, et al.
Publicado: (2019) -
Teratogenicity and Antiseizure Medications
por: Meador, Kimford
Publicado: (2020) -
Antiseizure medications and pregnancy
por: Moores, Ginette, et al.
Publicado: (2021) -
The evolution of antiseizure medication therapy selection in adults: Is artificial intelligence -assisted antiseizure medication selection ready for prime time?
por: Gunasekera, Charlene L., et al.
Publicado: (2023)